文献速递肝病

Sirtuin 3作为自噬的负调控因子决定肝细胞对脂毒性的易感性

Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity.
PubMed 文献 · Hepatology · 2017-07-20

本研究在小鼠和肝细胞中探讨SIRT3在饱和脂肪酸诱导脂毒性中的作用。富含饱和脂肪酸的高脂饮食比等热量不饱和高脂饮食更伤肝,且SIRT3表达与活性显著升高。SIRT3过表达使肝细胞和肝脏对棕榈酸诱导的细胞死亡更敏感,其机制为SIRT3负调控自噬,作者认为抑制SIRT3过度激活可能是NAFLD的潜在治疗选择。

要点

  • 富含饱和脂肪酸的高脂饮食比等热量不饱和高脂饮食对小鼠肝脏损害更重。
  • 饱和脂肪酸上调SIRT3表达与活性,SIRT3过表达加重棕榈酸诱导的肝细胞死亡。
  • SIRT3通过负调控自噬增强肝细胞对饱和脂肪酸诱导的细胞毒性的易感性。

核心结论

  • SIRT3是自噬的负调控因子,其被饱和脂肪酸激活后参与肝细胞脂毒性,作者认为抑制SIRT3过度激活可能是治疗NAFLD及其他以脂毒性为主要病理机制的代谢紊乱的潜在治疗选择。

研究设计与样本

  • 研究采用富含饱和脂肪酸的高脂饮食与等热量不饱和高脂饮食喂养的小鼠,以及培养的HepG2和AML-12肝细胞,并结合SIRT3小干扰RNA转染和SIRT3敲除小鼠肝脏组织进行机制探讨。

主要发现

  • 富含饱和脂肪酸的高脂饮食对肝脏的损害比等热量不饱和高脂饮食更严重,且暴露于该饮食的小鼠肝脏中SIRT3表达和活性显著升高。
  • 在HepG2和AML-12肝细胞中,饱和脂肪酸上调SIRT3表达和活性,而单不饱和脂肪酸无此作用。
  • SIRT3过表达使肝脏和肝细胞对棕榈酸诱导的细胞死亡更敏感,SIRT3小干扰RNA转染可减轻该细胞死亡,而SIRT3抑制则保护肝细胞免受棕榈酸细胞毒性。
  • 机制上,SIRT3过表达引起锰超氧化物歧化酶去乙酰化并激活,消耗细胞内超氧化物,导致AMPK抑制和mTORC1激活,从而抑制自噬;SIRT3小干扰RNA基因沉默则增强自噬流。
  • 在SIRT3敲除小鼠的肝脏组织中观察到类似结果。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Lipotoxicity induced by saturated fatty acids (SFAs) plays a central role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD); however, the exact mechanisms remain to be fully elucidated. Sirtuin 3 (SIRT3) is a nicotinamide adenine dinucleotide-dependent deacetylase located primarily inside mitochondria. In this study, we demonstrated that an SFA-rich high-fat diet (HFD) was more detrimental to the liver than an isocaloric unsaturated HFD rich in fatty acids. Unexpectedly, SIRT3 expression and activity were significantly elevated in the livers of mice exposed to the SFA-rich HFD. Using cultured HepG2 and AML-12 hepatocytes, we demonstrated that unlike monounsaturated fatty acids, SFAs up-regulate SIRT3 expression and activity. SIRT3 overexpression renders both the liver and hepatocytes susceptible to palmitate-induced cell death, which can be alleviated by SIRT3 small interfering RNA (siRNA) transfection. In contrast, SIRT3 suppression protects hepatocytes from palmitate cytotoxicity. Further studies revealed that SIRT3 acts as a negative regulator of autophagy, thereby enhancing the susceptibility of hepatocytes to SFA-induced cytotoxicity. Mechanistic investigations revealed that SIRT3 overexpression causes manganese superoxide dismutase deacetylation and activation, which depleted intracellular superoxide contents, leading to adenosine monophosphate-activated protein kinase (AMPK) inhibition and mammalian target of rapamycin C1 activation, resulting in autophagy suppression. In contrast, SIRT3 siRNA gene silencing enhanced autophagy flux. A similar result was observed in the liver tissue of SIRT3 knockout mice. CONCLUSION: Our data indicate that SIRT3 is a negative regulator of autophagy whose activation by SFAs contributes to lipotoxicity in hepatocytes and suggest that restraining SIRT3 overactivation can be a potential therapeutic choice for the treatment of NAFLD as well as other metabolic disorders, with lipotoxicity being the principal pathomechanism. (Hepatology 2017;66:936-952).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Li S, Dou X, Ning H, et al. Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity. Hepatology. 2017. PMID: 28437863. doi:10.1002/hep.29229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。